Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20102332 | 0.79 | KDM4E (0.32) | KDM4ESMN1; SMN2 | |
| SCHEMBL20102335 | 0.79 | — | — | |
| SCHEMBL20102326 | 0.74 | — | — | |
| SCHEMBL24703554 | 0.59 | KDM4E (0.57) | KDM4ESMN1; SMN2 | |
| SCHEMBL11740900 | 0.56 | L3MBTL1 (0.65) | KDM4ESMN1; SMN2 | |
| SCHEMBL7340852 | 0.55 | KDM4E (0.52) | KDM4ESMN1; SMN2 | |
| SCHEMBL16727947 | 0.55 | BRD4 (0.42) | SMN1; SMN2 | |
| SCHEMBL20022770 | 0.55 | — | — | |
| SCHEMBL14564387 | 0.54 | ALDH1A1 (0.57) | KDM4ESMN1; SMN2 | |
| SCHEMBL4938578 | 0.53 | ALDH1A1 (0.59) | KDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180118765-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | MUTABILIS (FR) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118765-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | NQO1, PEPD, LCT | KDM4E 3033/4885SMN1; SMN2 3965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.